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Abstract—Recently, Antimicrobial peptides (AMPs) have been 
area of interest in the researches, as the first line of defense 
against the bacteria. They are raising attention as an efficient 
way in fighting multi drug resistance. Discovering and 
identification of AMPs in the wet labs are challenging, 
expensive, and time consuming. Therefore, using computational 
methods for AMP predictions have grown attention as they are 
more efficient approaches. In this paper, we developed a 
promising ensemble learning algorithm that integrates well-
known learning models to predict AMPs.  First, we extracted the 
optimal features from the physicochemical, evolutionary and 
secondary structure properties of the peptide sequences. Our 
ensemble algorithm, then trains the data using conventional 
algorithms. Finally, the proposed ensemble algorithm has 
improved the performance of the prediction about 10% 
comparing to the traditional learning algorithms.  
Keywords-component; Antimicrobial peptides; Ensemble 
learning; Feature Selection; Bacteria; Prediction  
I.  INTRODUCTION  
Bacteria by far are the most diverse, and abundant organisms 
on Earth. They play an important role in human’s life and for 
decades they have been area of interest in researches [1-3]. 
Many researches have tried to understand their mechanism 
by clustering them, find their evolutionary history, or looking 
at their lateral gene transfer process [3-5]. Most of them have 
hoped their discoveries might facilitate the perceiving of 
bacterial antimicrobial-resistant which has become a real 
threat to global healthcare according to world health 
organization [6]. Attempts to fighting antimicrobial-resistant 
has led researchers to a key weapon provided by the nature: 
Antimicrobial peptides (AMPs).  
AMPs, which are suggested to be compelling against 
microorganisms such as virus, bacteria and fungi, are 
significant natural immune molecules that establishes a first 
line of host defense against microorganisms by damaging 
their cell membrane or their intracellular functions [7].  
Developing synthetic anti-microbial drugs can take years, 
and then antimicrobial resistance always emerges the need 
for new line of drugs. Because of these obstructions, AMPs 
have grown attention as an alternative option for 
conventional approaches [7].  
Discovering the AMPs in the wet-labs can be a challenge 
itself because it is still time consuming. Therefore, with the 
availability of enough data developing sequence-based 
computational tools have been found to be an effective way 
in identifying the peptides with high possibility of being a 
good AMP candidate [8]. Discovering these types of AMPs 
prior to the wet-lab experiments increases the probability of 
designing an AMP in a shorter time [8]. Here we discuss 
some of the most recent works that have applied the 
computational biology approaches to predict the AMPs.  
In [8], authors have developed a supervised learning 
algorithm to predict the AMPs. They first extracted physio-
chemical and structure-based features, then they trained a 
Support Vector Machine (SVM) using the input feature.  
Their approach increased the accuracy comparing to previous 
approaches; however, we suggest that accuracy could be 
increased using ensemble models comparing to a solo SVM.  
AMEP [9] is a more recent study that has applied an ensemble 
learning algorithm to predict the AMPs. Initially, they 
generated the distribution patterns of amino acids properties 
as features of the peptides, subsequently they used as input in 
Random Forest for prediction of AMPs. Their algorithm 
increased the accuracy comparing to the previous model. 
However, the precision for their algorithm is not as 
convincing as the accuracy.   
AMAP [10] is another machine learning algorithm developed 
to predict the antimicrobial activity of the peptides. AMAP 
has applied multi-label classification to predict several types 
antimicrobial peptides. They have evaluated their model 
using cross validation and compared to the state-of-the-art 
methods, and the result showed improvement in 
performance.  
All the methods mentioned above along with other 
computational tools listed in [11], have generated useful 
knowledge for the prediction of AMPs. However, 
minimizing the number of false positives by improving the 
algorithm is required. In this study, we made an attempt to 
develop a computational approach for prediction of 
antibacterial higher performance. Initially, we generate the 
features from physiochemical, evolutionary and secondary 
structure properties of the peptide sequences. Next, we 
reduce the dimension of the features and finally use them as 
an input for our ensemble machine learning algorithm.  Our 
approach found to be more accurate than existing approaches. 
This paper is organized as follows.  In section II explain our 
methodology in detail including data collection, feature 
extraction, and learning algorithms. Then in section III, we 
evaluate our approach. Section IV explains the conclusion of 
our work and future works.   
II. MTHODOLOGY  
In this section we have explained our methodology in detail.  
First how we collected the data, then features that we 
generated, and finally we have discussed the model we built.  
A. Data Collection 
We collected positive antibacterial peptides (ABPs) from 
several publicly available databases. We downloaded in total 
5000 positive ABPs available from Data Repository of 
Antimicrobial Peptides (DRAMP) [12], database 
Antimicrobial peptides (dbAMP) [13], and Collection of 
antimicrobial peptides (CAMP) [14].  For the negative 
dataset, we first computed the average weight of each amino 
acid in the positive data, and also length distribution of them. 
Then based on the result we generated 5000 negative peptides 
with the same weight and length distribution of the positive 
AMPs.  
Figure 1 plots the distribution of the length for positive and 
negative data, and figure 2 represents the distribution of the 
positive and negative data in terms of grand average of 
hydropathicity (gravy), and molecular weight of the 
sequences. The plots show how close the generated negative 
datasets are to the positive peptides. Using such a stringent 
dataset will affirm the result of model.  
B. Feature Extraction 
We extracted different features for the peptide sequences. We 
searched through recent researches to find the optimal 
features. A number of researches [15-17] have suggested 
using physicochemical, evolutionary and secondary structure 
properties as optimal features for the peptides.  
 
 
 
Figure 1- The distribution of the positive and negative AMPs in terms of 
the lengths and number in the dataset. 
 
 
Figure 2- The distribution of the positive and negative AMPs in terms of 
sequence grand average of hydropathicity (gravy), and the molecular 
weight of the sequence 
 
Table 1 lists the features that have been generated. Amino 
acid decomposition for each sequence is a fraction of the 
amino acids to the peptide length. The composition, 
transition, and distribution (CTD) model examines the 
physicochemical properties of the amino acids such as 
normalized van der Waals volume, hydrophobicity, polarity, 
polarizability, and secondary structure. There are 591 feature 
per sequence for these three feature sets. iFeature [17] is a 
python-based tool that has implemented the code for most of 
the protein sequence features. We used the classes developed 
by iFeature and also [15].  In order to mitigate the number of 
features, we first computed the Pearson’s correlation 
coefficient (1) between the features. 
𝑃𝑒𝑎𝑟𝑠𝑜𝑛(𝐴, 𝐵) =  
𝐸((𝐴 −  𝜇𝐴)(𝐵 − 𝜇𝐵))
𝜎𝐴𝜎𝐵
 
(1) 
Where 𝐸 is the expectation, and 𝜇A and 𝜇B are the mean 
values, and 𝜎A and 𝜎B are the standard deviations of A and B, 
respectively. The result of correlation is a number between [-
1, +1]. The farther from zero indicates the higher correlation 
between A, and B. Here, we kept the features with 
|correlation|<0.90. This way we reduced the number of 
features from 591 to 49. 
 
Table 1- Features for the peptides 
Feature  Dimension 
amino acid composition  
 
20 
composition, transition, and distribution 
(CTD) model  
168 
 
Predicted secondary structure 3 
position-specific scoring matrix (PSSM) 400 
 
C. Learning Algorithm 
We trained our model using three well-known machine 
learning algorithms: Support Vector Machine (SVM) [18], 
Random Forest (RF) [19], Gradient Boost Model (GBM) 
[20]. Then we developed an ensemble [15] algorithm that 
utilizes the learning by combining the three algorithms.  
 
1) SVM 
Support Vector Machine (SVM) is a non-probabilistic, linear, 
binary classifier that can be used for both regression and 
classifying data by learning a hyperplane which divides the 
classes of the data. SVM basically learns an (n – 1)- dimension 
hyper plan for an n-dimensional space into two classes. SVM 
can be also used for classifying a non-linear dataset by 
projecting the dataset into a higher dimension in which it is 
linearly separable. It has low performances when the data is 
noisy.  
2) Randome Forest 
Random forest [19] is a well-known ensemble algorithm that 
works by combining a large number of decision trees. The RF 
algorithm operates by voting. It simply benefits from the 
wisdom of the crowd. Every individual tree in the random 
forest predicts a class for the datapoint and the class with the 
highest number of votes turns into the final prediction. 
Training a large number of the uncorrelated decision trees is 
the key that RF works well. Uncorrelated trees lead to a higher 
accurate prediction, and also the trees protect each other from 
their individual errors. For building a random forest model, 
the features and in result the trees generated based on those 
features are required to have low correlation.  
 
3) Gradiant Boost Model 
Gradient boosting is another ensemble learning algorithm that 
predictors are not independent, and they work sequentially.  
The gradient boosting algorithm (GBM) is basically a 
technique for both regression and classification problems. It 
generates a prediction model in the form of an ensemble of 
weak prediction models, typically decision trees. It builds the 
model in a stage-wise fashion like other boosting methods do, 
and it generalizes them by allowing optimization of an 
arbitrary differentiable loss function. 
 
4) Ensemble Method  
We generated an Ensemble learning algorithm using RF, 
GBM and SVM. As we can see in figure 3, first the base 
classifiers (RF, GBM, and SVM), take the training dataset as 
input, then they provide a decision individually. We have 
mapped the categorical labels “positive” and “negative” to 1, 
and 0 respectively. Let’s the output of their decision be ORF, 
OGBM, and OSVM, then the final decision is calculated as 
follows (2). 
𝑓 =  
𝑂𝑅𝐹 + 𝑂𝐺𝐵𝑀 + 𝑂𝑆𝑉𝑀
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(2) 
if {
𝑓 == 1     →     𝑆𝑡𝑟𝑜𝑛𝑔 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒
𝑓 > = 0.66 →   𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒               
𝑓 < = 0.33 →   𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒              
𝑓 == 0     →     𝑆𝑡𝑟𝑜𝑛𝑔 𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒
 
(3) 
 
The final decision is made based on the result of the f . We 
are able to make suggestion about the probability of being 
positive or negative based on the result of f. However, the 
final decision for classifying into two classes is if f>0.5 the 
prediction is positive otherwise it is negative.  
 
 
Figure 3- Ensemble method created by RF, GBM, and SVM 
III. RESULTS 
For evaluating our model, we used four different evaluation 
metrics [21]: Accuracy (4), F1 Score (5), Recall (6), and ROC 
(7). First we define True Positives (TP), True Negatives 
(TN), False Positives (FP) and False Negatives (FN).  
TPs are the peptides correctly predicted as antibacterial 
peptides.  TNs are peptides that are correctly predicted as not 
antibacterial peptides.  FPs occur when a not antibacterial 
peptide is predicted as antibacterial. FNs happens when the 
predicted value indicates the peptide is not antibacterial, 
while the actual value is antibacterial peptide. The evaluation 
metrics are defined based on these parameters. 
 
𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =  
𝑇𝑃 + 𝑇𝑁
𝑇𝑃 + 𝑇𝑁 + 𝐹𝑃 + 𝐹𝑁
 
(4) 
𝑅𝑒𝑐𝑎𝑙𝑙 =  
𝑇𝑃
𝑇𝑃 + 𝐹𝑁
 
(5) 
𝐹1 𝑆𝑐𝑜𝑟𝑒 =  
2𝑇𝑃
2𝑇𝑃 + 𝐹𝑃 + 𝐹𝑁
 
(6) 
𝐹𝑃𝑅 =  
𝐹𝑃
𝐹𝑃 + 𝑇𝑁
 
(7) 
𝑇𝑃𝑅 =  
𝑇𝑃
𝐹𝑁 + 𝑇𝑃
 
(8) 
The Receive Operating Characteristic (ROC) curve is the 
created by plotting TPR against FPR. It shows the ability of 
the model to classify a binary dataset.  
We hold out 25 percent of the data as test, and trained the 
model using the 75% of the data. Table 2 compares the 
performance result for the ensemble method and three 
individual models. 
Table 2- Performance Evaluation 
Method Accuracy F1 Score Recall 
SVM 0.75 0.73 0.69 
GBM 0.63 0.61 0.58 
RF 0.76 0.76 0.74 
Ensemble 0.87 0.86 0.86 
 
The table shows that generally there is almost 10 percent 
improvement in prediction using the ensemble method. The 
higher F1 score means, the ensemble has been able to improve 
the precision of the model.  
 
 
Figure 4 – The ROC curve for the proposed ensemble method and for three 
other individual learning algorithms 
 
Figure 4 plots the ROC curve for the ensemble algorithm and 
three individual algorithms.  The figure shows that all the 
models are better than random selecting the peptides. SVM 
works better than other two models. The Ensemble model 
benefits from combining the three models, and the higher 
area under curve (AUC) shows the improvement.  
IV. CONCLUSION 
Recently, predicting antimicrobial peptides has grown 
attention. In this work we developed a learning algorithm to 
predict the antibacterial peptides. The contribution of our 
work comes from combining well-know algorithms to 
generate a more powerful learning algorithm. We trained and 
tested our results using a highly stringent data, and the result 
shows almost 10% performance improvement. For the future 
work, we will design an ensemble model for predicting all 
types of antimicrobial peptides. Also, we will try to design a 
meta classifier to improve our model even more.  
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